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Altered calcium metabolism in chronic renal failure. A compart-
mental analysis of 47Ca tracer kinetic data and Ca balance
measurements was employed to evaluate several indexes of Ca
metabolism in patients with mild to severe renal insufficiency.
Rates of Ca accretion and resorption and the size of the ex-
changeable Ca pools were measured. In addition, absolute
measurements were made of total body Ca, P, Cl and Na by
means of neutron activation analysis. Total body K was
measured by whole-body counting. Total body levels of Ca, P,
Na, Cl and K in patients with modest renal insufficiency did not
differ from those of a normal contrast population. In patients
with severe renal failure, however, there were a number of
changes in Ca and P metabolism. The total body P/Ca and P/K
ratios were increased above normal. Most of the patients with
renal insufficiency had total body Ca levels within the normal
range, when normalized for skeletal size and the age and sex of
the patient. The levels of total body Ca were inversely related to
the accretion rate of Ca into bone; that is, the patients with the
greatest calcium deficit had the highest accretion rate. Altera-
tions in compartment sizes and intercompartmental transfer
rates were observed in severe renal failure. The increased size of
an exchangeable Ca compartment together with the essentially
normal levels of total body Ca suggest a translocation of
skeletal Ca to soft tissue mediated by increased parathyroid
hormone secretion. Further studies, including a measure of the
size of the soft tissue and skeletal compartments, are required to
substantiate this hypothesis.
Le modification du métabolisme du calcium dans l'insuffisance
rénale chronique. Une analyse compartimentale des résultats de
cindtiques du traceur 47Ca et du bilan de calcium a été employee
pour dvaluer divers paramétres du métabolisme du calcium chez
des malades atteints d'insuffisance rénale moyenne ou sévére. Les
debits d'accretion et de resorption et Ia taille des pools échange-
ables de calcium ont ete determines. De surcroit les mesures des
masses corporelles totales de Ca, P, Cl et Na ont dté faites au
moyen de l'activation neutronique. Le potassium total corporel
a été mesuré par comptage corporel total. Les masses cor-
porelles de Ca, P, Na, Cl et K des malades atteints d'insuffisance
rénale modest ne sont pas différentes de celles d'une population
normale. Chez les malades atteints d'insuffisance rénale sévére,
cependant, il existe des modifications des métabolismes de Ca
et P. Les rapports P/Ca et P/K de l'organisme entier sont
augmentés par rapport aux valeurs normales. La plupart des
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malades atteints d'insuffisance rénale ont un Ca total dans
l'éventail des valeurs normales quand les données sont corrigées
par la masse du squelette l'age et le sexe du malade. Le Ca total
corporel est inversement corréld au debit d'accrétion du Ca
dans l'os; c'est-à-dire que les malades qui ont le deficit en cal-
cium le plus grand ont aussi le debit d'accretion le plus eleve.
Des modifications de la taille des compartiments et des debits
de transfert ont ete observes dans l'insuffisance renale sévére.
L'augmentation de Ia taille d'un compartiment de Ca echange-
able alors que le Ca total corporel est normal suggére une trans-
location du calcium squelettique vers les tissus mous sous
l'influence d'une secretion accrue d'hormone parathyroidienne.
Des travaux supplémentaires comprennant une mesure de Ia
taille des compartiments tissulaires et squelettique sont néces-
saires pour étayer cette hypothése.
Abnormalities of calcium (Ca) and phosphorus (P)
metabolism in patients with renal insufficiency have
been characterized in a number of studies [1—14].
Increased parathyroid hormone secretion [5], altered
vitamin D metabolism, with concomitant malabsorp-
tion of Ca [6], and acidosis [7] have been indentified
as important determinants of the altered Ca and P
metabolism observed in patients with renal osteo-
dystrophy.
The various methods used to determine the nature
and degree of changes in Ca metabolism have signifi-
cant limitations. For example, histological changes
observed from bone biopsy specimens are not readily
quantified and, further, provide information only on
localized areas of bone. Photon absorptiometric
techniques, while highly quantitative and precise,
again provide information only on localized areas of
the skeleton. Measurements made by radiographic
technique can be applied to the entire skeleton, but
these measurements lack the sensitivity required for
quantifying levels of change associated with the
development of pathological conditions.
Some of these difficulties are resolved by the use of
total body neutron activation analysis (TBNAA),
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which permits the direct in vivo measurement of total
Ca and P content of the body to be made with a high
degree of precision. Further, metabolic bone disease
can also be evaluated in terms of bone turnover (i.e.,
bone mineral accretion and resorption) and by Ca
absorption and endogenous excretion measurements.
Ca tracer kinetic studies along with metabolic balance
studies provide useful information on the internal
compartmentalization and transfer of Ca in uremic
patients. The simultaneous application of these tech-
niques should provide a better understanding of Ca
metabolism in renal failure.
Methods
Patients. Thirteen patients with modest to severe
renal insufficiency were studied. Brief clinical descrip-
tions of each patient along with biochemical concen-
trations in the plasma are presented in Table 1. The
patients were divided into two groups. Group I con-
sisted of six patients with modest to mild renal insuffi-
ciency. Creatinine clearance (glomerular filtration rate,
GFR) exceeded 10 ml/min in all patients. Although
azotemic for a variable period of time (0.5 to 5 yr),
group I patients were not hypocalcemic, hyperphos-
phatemic or acidotic. All patients in this group
exhibited stable azotemia for at least four months
prior to the study. Sodium bicarbonate and aluminum
hydroxide gel were administered to patient 1 for six
months prior to the study. Patient 4 received calcium
carbonate (3.6 g/day) and aluminum hydroxide gel for
two months prior to the study. Patients 2, 3, 5 and 6
had been treated with corticosteroids or immuno-
suppressives, or both, for variable periods of time
before the study. Patients 3 and 5 had not received
these medications for at least three months, while
patients 2 and 6 had not been treated with steriods or
immunosuppressives for a period of one year. Radio-
graphic examination of the members of this group
revealed mild demineralization and subperiosteal bone
resorption. Patients 1 and 4 exhibited, in addition,
modest vascular calcification.
Group 11 consisted of seven patients with severe
renal failure. Creatinine clearance was less than 10
mI/mm in all patients. Hypocalcemia and hyper-
phosphatemia were evident in all patients. Azotemia
was of a longer duration in this group (three to eight
years) and was stable for at least six months prior to the
study. All patients in this group were prescribed alu-
minum hydroxide gels for many months prior to this
study but the degree of adherence to this therapy was
variable. In addition, patients 7, 10 and 11 received
sodium bicarbonate and calcium carbonate (3.6 g/day)
for six months to one year prior to the study. Patient
S had been treated with corticosteroids and immuno-
suppressives for two years at the onset of the disease
but had not received these medications for six years.
Sketetal roentgenograms of patients in this group
were characterized by only modest demineralization
and subperiosteal resorption. Plasma alkaline phos-
phatase and total protein and albumin concentrations
were within normal limits for patients in both groups.
Table 1. Clinical description of patientsa
Patient
No.
Age Sex Weight
kg
Height
cm
GFR
mi/mm
Plasma Duration
of
azotemia
Diagnosis
Cr Urea N Ca P HCO3
mg/IOO ml mg/IOO ml mg/100 ml mg/iOO ml mEq/liter yr
Group I
1 49 F 61.9 170.2 11 6.7 112 9.9 5.2 23 5 CP
2 46 M 109.4 177.5 20 5.5 74 9.5 5.0 20 2 CGN
3 50 M 93.4 172.7 60 2.0 30 9.9 3.4 30 0.5 CGN
4 60 F 51.4 160.5 12 4.6 44 9.5 5.3 25 0.5 ARF
5 63 M 87.5 171.2 33 3.1 25 9.8 2.9 28 1 NS
6 53 M 82.3 168.0 45 1.8 25 9.1 2.4 33 3 CGN
Mean 30 4.0 52 9.6 4.0 26 2
Group II
7 50 M 81.7 177.8 5 17.0 142 6.3 6.9 17 4 CRD
8 22 F 53.6 159.8 9 7.7 92 8.4 7.1 17 8 CGN
9 53 F 45.0 153.7 2 16.0 270 8.6 12.4 11 8 PRD
10 17 F 45.4 158.0 3 13.3 263 6.3 12.6 19 8 PRD
11 43 F 60.9 162.0 3 15.0 114 6.8 5.5 20 5 PRD
12 35 M 63.2 159.7 6 12.3 121 7.1 7.0 20 3 CRD
13 47 F 67.3 152.9 8 7.1 100 8.5 5.5 18 5 CRD
Mean 5 12.6 157 7.4 8.1 17 6
CP = chronic pyelonephritis; CGN = chronic glomerulonephritis; ARF = acute renal failure; NS = nephrotic syndrome; PRD = polycystic
renal disease; CRD = chronic renal disease of unknown etiology.
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Experimental design. All patients ingested a con-
stant diet containing 500 mg of Ca and 800 mg of P
for seven to ten days before and nine days after injec-
tion of 47Ca. After seven to ten days of equilibration to
a constant diet on a metabolic ward, 47Ca (20 PCi;
specific activity, 1.40 mCi/mg) was administered i.v.
to each subject. The plasma activity was measured at
1 hr, 6 hr and, thereafter, every 24 hr for a period of
nine days. The whole body concentration of 47Ca was
measured daily with the Brookhaven whole body
counter. Stool and urine were collected over 24-hr
periods and analyzed for stable and radiocalcium.
The compartmental model of radiocalcium kinetics
(Fig. 1); the experimental details of the measurement
of 47Ca in plasma, urine and feces; and the use of a
digital computer program to analyze the kinetic
data have been previously described [15]. The Berman
simulation analysis and modeling (SAAM) program
(modified for the CDC-6600 computer) was used to
adjust the parameters of the above mathematical
model to the data [15]. The program obtains, by an
iterative system, the best coefficients for a given set of
differential equations describing the model. This set of
coefficients is then used to determine the desired para-
meters of the system, the sizes of the compartments and
the transfer rates between them. The flow rates are then
calculated from the product of the transfer rate and
compartment size. The parameter values with their
Fig. 1. The compartmental model of radiocalcium kinetics. Com-
partments are designated as follows: Compartment 1 represents
the pooi of Ca in isotopic equilibrium within one hour after
injection. Compartment 2 represents the physiologic pool of Ca
in isotopic equilibrium within three days. Compartment 3 is
assumed to represent very slowly exchanging calcified tissue.
The transfer constants are designated as follows: plOCa
intake; p21 =rate of transfer of Ca to compartment 2; p13 =
rate of resorption and slow exchange from bone and extraos-
seous calcification to blood; p31 = the rate of accretion into bone
and extraosseous calcification; p4l = urinary Ca excretion rate;
p51 = the endogenous fecal Ca excretion rate.
computational errors provide an objective quantitative
comparison of the fit of the 47Ca data.
The radiocalcium kinetic data obtained for patients
with renal insufficiency were compared to a pre-
viously reported normal population [16] utilizing the
National Institutes of Health (NIH)-SAAM program
analysis [15]. Total body Ca (TB0a) and total body
potassium (TBK) in these normal subjects were estima-
ted from height and weight [17].
Total body levels of Ca, Na, Cl and P were mea-
sured by in vivo neutron activation analysis [18]. In
addition, absolute levels of total body K (40K) were
measured by whole body counting. Total body levels
of these elements were measured in the patients with
renal failure and in a contrast normal population. This
latter group consisted of normal volunteers without
evidence of renal, bone, metabolic or cardiovascular
disease.
In order to calculate the relative deficit in TBa in
individual patients from the absolute measurement
of TBca, it is necessary to normalize the data for each
patient with a correction based on sex, age and skeletal
size. The variation in Ca content of an individual is
large because of variation in the size of the individual
as well as in the degree of mineralization. Thus, in
addition to the need for an accurate method of
measuring the calcified tissue mass, a standard refer-
ence is needed against which the measurement may be
compared.
To normalize the absolute TB0a measurement, the
following algorithm was used to calculate the "normal"
(i.e., predicted) TB0a in a subject based on his weight
(lean body mass), height, sex and age [17, 18]:
TBCaE = aH ./K where TBCaE = Predicted normal
total body Ca (g).
H = the height (m); K = the total body potassium (g);
crm=54.4 for males; af=57.0 for females.
The measured TBca, expressed in terms of the
predicted normal calcium (TB05), is referred to as the
calcium ratio. The relative deficit for an individual
patient is then 1 —Ca ratio. In the normal subjects,
the Ca ratio is 1.0 (2sD).
Ca balance studies were performed on the metab-
olic research ward of the Brookhaven National
Laboratory Hospital. The methods followed were
essentially those outlined by Reifenstein, Albright and
Wells [19]. Diet and feces were ashed in a muffle
furnace before Ca analysis. Pooled nine-day lots of
stool were analyzed and average daily fecal Ca excre-
tion calculated. Urine and serum were analyzed
directly. Fecal and dietary Ca was determined by
atomic absorption spectrometry [20]; urine and plasma
Ca and P, urea nitrogen (urea N), creatinine (Cr) and
plo
p!3
4
p51
5
48 Letter! et a!
bicarbonate (HCOa) concentrations were measured by
standard methods utilizing an autoanalyzer.
Results
Body composition in renal insufficiency. The values of
TBa, TB, TB1, TBK and TBNa obtained in the groups
of renal failure patients and the mean values noted in
14 normal patients are listed in Table 2. The ratio of
TBca to lean body mass (TBK) in group I and group II
did not differ significantly from that found in the
normal subjects.
The TBca/TBcaa ratio in patients with renal failure
was variable. In five of six patients in group I, the Ca
ratio was within normal limits (0.9 to 1.1). The TBCa/
TBCaE ratio was decreased in three patients in group H,
but was within normal limits or increased in four other
patients in the group. Three of these latter patients had
polycystic renal disease.
TBca, whether expressed in absolute terms or rela-
tive to lean body mass (TBK), did not correlate with
GFR or the plasma HCO3 or plasma Ca concen-
trations.
TB expressed in terms of calcified tissue mass
(TBca) or lean body mass (TBK) is significantly higher
in patients with renal insufficiency than in normal
subjects. The P/Ca ratio was increased in eight of ten
patients with GFR less than 20 mI/mm. The relation-
ship between the total body P/Ca ratio, plasma P and
GFR is depicted in Fig. 2. All patients with plasma P
in excess of 6 mg/100 ml had increased P/Ca ratios.
The total body Na/K ratio was significantly in-
creased in group II patients above mean values obser-
ved in the normal subjects. No significant differences in
body composition with regards to K or Cl were noted
among subjects in group I, group Ii and normal
subjects.
Radiocalcium kinetics in renal insufficiency. The
values of the transfer rates and compartment sizes and
the error in the computer-derived values for the
model system are listed in Table 3. The computer-
derived fit of the model to the experimental data
obtained in renal insufficiency is as good as that
previously observed in normal control subjects indi-
cating that the model represents the kinetic data for
individuals with renal failure very well [15]. In Table 4,
the mean kinetic data relative to TB0a in the two
groups of patients are compared to the mean of data
from normal subjects previously reported [15, 16].
In patients with modest renal insufficiency, (group
I), the following indexes of Ca metabolism as esti-
Table 2. Body composition in renal insufficiency
Patient
No.
TB
g
TBK
g
TB1
g
TBNI
g
TB
g
Ca/K Na/K Na/Cl P/Ca P/K TBCa
TBCaE
Group I
1
2
3
4
5
6
840
1134
1086
512
1182
1061
89.7
147.9
127.8
65.0
97.4
119.6
69.6
99.1
75.2
54.5
76.7
72.4
73.8
98.2
92.2
56.8
94.4
77.5
529
660
566
281
517
438
9.36
7.67
8.50
7.88
12.14
8.87
0.82
0.66
0.72
0.87
0.96
0.65
1.06
0.99
1.23
1.04
1.23
1.07
0.63
0.58
0.52
0.55
0.44
0.41
5.90
4.46
4.43
4.32
5.31
3.66
0.914
1.014
1.054
0.619
1.178
1.077
Mean
SEM
969
103
107.9
12.1
74.6
5.9
82.2
6.4
498
53
9.07
0.66
0,78
0.05
1.10
0.04
0.52
0.03
4.68
0.33
0.976
0.079
Group II
7
8
9
10
11
12
13
1259
708
733
729
817
791
622
120.1
81.0
59.4
72.1
66.0
105.4
74.3
105.0
78.9
71.9
49.0
57.2
55.7
69.6
90.4
70.0
69.6
57.5
63.0
61.1
63.2
594
431
670
529
392
444
696
10.48
8.74
12.34
10.11
12.38
7.5
8.36
0.75
0.86
1.17
0.71
0.95
0.58
0.85
0.86
0.89
0.97
1.05
1.10
1.10
0.91
0.47
0.61
0.91
0.73
0.48
0.56
1.12
4.95
5.32
11.28
7.34
5.94
4.21
9.37
1.120
0.881
1.009
0.924
0.961
0.885
0.828
Mean
SEM
808
79
82.6
8.3
69.6
7.1
67.8
4.1
537
46
9.99
0.72
084b
0.07
0.98
0.04
0.70°
0.09
6.920
0.98
0.944
0.036
Normal mean
SEM
N= 14
1015
53
117.9
8.8
75.2
3.2
78.9
3.9
472
29
8.84
0.28
0.69
0.02
1.05
0.02
0.47
0.02
4.11
0.21
1.000
0.010
° TB0= total body calcium; TBK =total body potassium; TB1 = total body chloride; TBN = total body sodium;
TB = total body phosphorus; Ca/K= ratio of TBCa/TBK; Na/K, ratio of TBNO/TBK; Na/Cl = ratio of TBNO/TBCI;
P/Ca= ratio of TB/TB0; P/K= ratio of TBP/TBK; TBCO/TBCOE = ratio of measured TBca to estimated TB0.
b Value is significantly greater than normal, F <0.05 as determined by covariance analysis.
° Values are significantly greater than normal, F <0.01 as determined by covariance analysis.
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mated by compartmental analysis are not significantly
different from the normal mean values: compartment 1,
compartment 2, the rates of exchange, accretion and
resorption rate. Patients with severe renal failure
(group II) were characterized by a marked increase in
exchange rate (pl2, 21) and a significant increase in the
size ofcompartment2. In both groups of renal patients,
the accretion rate and compartment 2 were inversely
related to the TBCa/TBCaE ratio (Figs. 3 and 4).
Further, a linear relationship was noted between the
size of compartment 1 and the plasma Ca concentra-
tion. This relationship is significant (r =0.763,
P<0.0l) only if patient 13 is excluded from the
patient population (Fig. 5). Endogenous fecal Ca
excretion was not significantly different from normal
values in both groups of patients. Urinary Ca excre-
tion was significantly decreased below normal values
and strikingly correlated with GFR in both groups of
patients.
Calcium balance in renal insufficiency. The data
obtained from Ca balance studies on each patient are
shown in Table 5. In group I (patients with a GFR of
more than 10 mI/mm), the total fecal Ca excretion
exceeded Ca intake in only one individual (patient 2),
0.6 0.17 0!8 0! 1.1 i2
TBC/TBcaE
Fig. 3. The relationship between accretion rate and the ratio of
the observed to estimated total body calcium (TBca/TBcE).
Accretion rate is corrected to 1000 g TB0a. The normal limits
of accretion rate and TBC/TBCaE are depicted by cross-hatched
area with 95% confidence. The line is drawn by visual approxi-
mation.
thus producing a negative Ca balance. In group II
(patients with a GFR less than 10 mI/mm), the total
fecal excretion exceeded Ca intake in three of seven
patients, thus producing a negative Ca balance.
Positive Ca balance (>100mg/day) was observed
in three patients with a GFR less than 5 ml/min
and polycystic renal disease.
Discussion
Total body levels of Ca, Na, K, P and Cl in patients
with modest renal insufficiency were not significantly
different from those of persons in the contrast popu-
lation. This would indicate that in the early stages of
renal disease no significant abnormalities of body
composition develop with regard to these elements.
However, patients with severe renal failure exhibited
an increased total body P/Ca ratio, as well as an
increased P/K ratio (i.e., phosphorus normalized to
the lean body mass). This increased P was noted
particularly in patients with plasma P in excess of
6.0 mg/100 ml and a GFR less than 20 mI/mm (Fig.
12.6
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Fig. 2. The total body P/Ca ratio in relation to glomerularfiltra-
tion rate and plasma P concentration. Open circles depict plasma
P concentration; closed circles depict the total body P/Ca ratio.
The cross-hatched area depicts the normal limits of the TB P/Ca
ratio with 95% confidence.
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2). This finding confirms a previous observation that
phosphate retention occurs in patients when the GFR
decreases below 20 mI/mm [25]. Recent studies have
also reported an increased P content of uremic bone
[26, 27].
It was observed that in most patients with renal
insufficiency, the total body Ca, when normalized
for skeletal size, sex and age of the individual
(TBCa/TBCaE) was generally within 10% (2 SD) of
the mean of the normal contrast population. The
patients with the significantly low Ca ratio all
had a high accretion rate of Ca into bone (p3l). In
fact, a significant inverse relationship was observed
between the Ca ratio (TBCa/TBCaE) and the accre-
tion rate in patients with renal failure (see Fig. 3).
Thus, when the Ca ratio was less than 0.95, the
accretion rate increased to 1.4 to 2.0 g/day/kg of
TB0a. When the Ca ratio was greater than 0.95
(i.e., essentially normal), the accretion rate was normal
or below the normal range. Thus, in what appears to
Table 3. Radiocalcium kinetics in renal insufficiencya
Patient
No.
Compartment, g Urine
p41
2 g/day
Stool
pSi
g/day
Accretion
p31
g/day
Exchange
p12, 21
g/day1 2 1 and
Group I
1
2
3
4
5
6
Group II
7
8
9
10
11
12
13
2.13 2.34 4.47 0.0130 0.115 0.514 1.27
±0.23 ±0.52 ±0.73 ±0.0009 ±0.101 ±0.013 ±0,25
(11%) (22%) (16%) (7%) (11%) (2%) (20%)
2.72 2.17 4.89 0.0113 0.089 0.246 1.47
±0.31 ±0.47 ±0.80 ±0.0012 ±0.010 ±0.011 ±0.21
(11%) (22%) (16%) (10%) (11%) (4%) (14%)
1.99 2.19 4.19 0.0471 0.089 0.401 4.78
±0.28 ±0.41 ±0.45 ±0.0033 ±0.009 ±0,011 ± 1.74
(14%) (19%) (11%) (7%) (11%) (3%) (36%)
1.49 2.21 3.70 0.0201 0.088 0.762 2.38
±0.09 ±0.16 ±0.22 ±0.0007 ±0.004 ±0.005 ±0.27
(6%) (7%) (6%) (3%) (5%) (1%) (11%)
3.67 2.61 6.28 0.035 0,093 0.361 2.28
± 0.37 ±0.44 ± 0.75 ± 0.003 ± 0.008 ± 0.010 ± 0.71
(10%) (16%) (12%) (7%) (8%) (3%) (31%)
2.17 3.21 5.38 0.133 0.042 0.475 2.19
±0.21 ±0.51 ±0.71 ±0.009 ±0.004 ±0.012 ±0.29
(10%) (16%) (13%) (7%) (10%) (3%) (14%)
1.83 2.23 4.06 0.0118 0.067 0.274 4.40
±0.32 ±0.52 ±0.68 ±0.0014 ±0.009 ±0.010 ± 1.73
(17%) (23%) (17%) (12%) (14%) (4%) (39%)
1.94 3.16 5.09 0.0024 0.114 0.963 1.44
±0.18 ±0.50 ±0.64 ±0.0001 ±0.011 ±0.011 ±0.20
(9%) (16%) (12%) (5%) (10%) (1.2%) (14%)
1.67 1.58 3.25 0.0210 0.077 0.199 2.52
±0.19 ±0.27 ±0.39 ±0.0016 ±0.007 ±0.008 ±0.87
(12%) (17%) (12%) (8%) (9%) (4%) (34%)
1.00 2.69 3.69 0.0151 0.049 0.696 2.40
±0.12 ±0.29 ±0.34 ±0.0006 ±0.004 ±0.004 ±0.36
(12%) (11%) (9%) (4%) (8%) (0.6%) (15%)
1.48 2.01 3.49 0.009 0.103 0.297 3.40
±0.16 ±0.26 ±0.31 ±0.0005 ±0.008 ±0.009 ±0.82
(11%) (13%) (9%) (6%) (8%) (3%) (24%)
1.35 2.17 3.52 0.0089 0.079 0.542 2.44
±0.09 ±0.15 ±0.18 ±0.0002 ±0.004 ±0.004 ±0.33
(6%) (7%) (5%) (2%) (5%) (0.7%) (14%)
3.60 3.40 7.00 0.0317 0.136 1.63 1.81
±0.31 ±0.48 ±0.70 ±0.001 ±0.013 ±0.014 ±0.36
(8%) (14%) (10%) (4%) (9%) (0.8%) (20%)
a See legend to Fig. I for definition of terms, The computer-calculated errors of the various indexes; also shown as
percent errors.
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Table 4. Comparison of radiocalcium kinetics in renal insufficiency with normal patientsa
Compartment, g/kg of TB Transfer rates, g/day/kg of TBca
1 2 1 and 2 Urine
p41
Stool
p51
Accretion
p31
Exchange
p12. 21
Group I
Mean
SEM
2.48
0.19
2.72
0.36
5.21
0.46
0.0443
0.0141
0.106
0.022
0.575
0.190
2.67
0.62
Group II
Mean
SEM
2.45
0.58
3.26
0.51
5.70
1.03
0.0194
0.0007
0.119
0.020
0.925
0.322
3.10
0.25
Normal mean'
SEM
N= 23
Group I vs. group JJc
Group I vs. normale
Group II vs. normale
2.86
0.13
NS
NS
NS
2.14
0.17
NS
NS
0.025
5.00
0.22
NS
NS
NS
0.150
0.001
NS
0.001
0.001
0.134
0.002
NS
NS
IVS
0.405
0.024
NS
NS
NS
1.72
0.36
NS
NS
0.001
a See legend to Fig. 1 for definition of terms.
b Normal values are corrected to TBa of 1000 g based on height and weights reported by Heaney et al [161 and Cohn et al [15].
P value for each of the groups as determined by Student's I test.
Table 5. Calcium balance in renal insufficiency (mg/day)a
Patient
No.
Intake Total
fecal
Endo
fecal
Net
fecal
Absorption Urine Accretion
rate
Resorption
rate
Ca
balance
Group I
1 567 519 115 404 163 16 514 482 32
2 478 489 89 400 78 16 246 273 —27
3 483 407 89 318 165 51 401 376 25
4 538 394 88 306 232 22 762 640 122
5 497 386 93 293 204 35 361 285 76
6 573 411 42 369 204 133 475 446 29
Mean 522 434 86.0 348 174 45.5 460 417 43
SEM 17 23 9.7 20 22 18.3 72 56 16
Group II
7 567 416 67 349 218 23 274 146 128
8 479 575 114 461 18 3 963 1062 —99
9 516 412 77 335 181 27 199 122 77
10 507 378 49 329 178 15 696 582 114
11 486 300 103 197 289 12 297 123 174
12 573 641 79 562 11 3 542 613 —71
13 480 638 136 502 0 31 1630 1819 —189
Mean 515 480 89.3 390 142 16.3 657 745 19
SEM 15 51 11.3 47 39 4.2 191 250 17
a Intake=intake of Ca in diet; total fecal =total fecal Ca excretion; endo fecal = endogenous fecal Ca excretion
into the gastrointestinal (GI) tract; net fecal= total fecal—endogenous fecal Ca excretion; absorption= net absorp-
tion of Ca across the GI tract; urine = urinary Ca excretion; accretion rate = bone formation rate or transfer of Ca
from compartment ito compartment 3 (p3l); resorption rate = bone resorption rate (pi 3); Ca balance = Ca intake —
total fecal excretion and urinary Ca excretion.
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Fig. 5. The relationship between plasma Ca Concentration and
compartment 1. The open circle represents patient 13 who is
excluded from the calculation of the regression line. The cross-
hatched area depicts the normal limits of compartment 1 with
95% confidence.
In addition, technical errors, such as incomplete stool
collection (since no markers were used in the present
study) could lead to relatively large cumulative error
with this sensitive technique.
The present study illustrates how short-term balance
studies and the new technique of TBNAA complement
each other and provide new and useful data. The
balance data obtained over a period of a few weeks
provide a sensitive differential measure of the direc-
tion and rate of change of total body Ca at that point in
time. The measurement of TB0a by neutron activation,
on the other hand, provides a direct and accurate
integral measure; i.e., the sum of all previous changes
in Ca balance.
Finally, several interesting observations were made
from a study of the compartmental analysis of the Ca
kinetic data. In early stages of renal failure, prior to
the development of severe metabolic acidosis, the
distribution and metabolism of Ca in the patient
does not differ significantly from that of individuals in
the normal contrast population. No significant changes
appear in the values for compartment sizes and inter-
compartmental transfer constants for group I patients.
However, as renal disease progresses into severe renal
failure with attendant systemic acidosis, compart-
ment 2 increases in size, and the intercompartmental
flux (pl2, 21) also increases as compared to the normal
value.
The size of compartment 1 in the renal patients did
not differ significantly from that of members of the
contrast population. Interestingly, a linear relation-
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Fig. 4. The relationship between the compartment 2 and the
TBc,/TBcE ratio. The cross-hatched area depicts the normal
limits of both of these variables with 95% confidence. Excluding
patient 4, the relationship between these variables is highly
significant (r=0.72, P<0.01, y= —7.58 x + 10.37).
be a homeostatic relationship, the accretion rate of Ca
into bone increased when the total body Ca fell below
the predicted normal value.
A similar relationship exists between the Ca
ratio and the size of compartment 2 (see Fig. 4). As
the total body Ca deficit increases, the size of the
exchangeable Ca, compartment 2, also increases.
(However, since the exact physical analog of compart-
ment 2 has not been identified, it is difficult to draw any
conclusions from these data vis-a-vis the increased
Ca deposition in the soft tissue.)
The Ca balance was variable, and tended to be
slightly positive in most patients in the short-term
study. While the balance data are in contrast to the
negative Ca balance data reported by a number of
investigators, they are consistent with the normal
values for total body Ca as measured here by
TBNAA. it must be noted, however, that Ca absorp-
tion, and hence Ca balance, is a function of a number
of poorly defined factors such as the dietary intake,
type and duration of the disease and previous thera-
peutic regimens, all of which may influence the results.
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ship was observed between the size of compartment 1
and the concentration of plasma Ca (see Fig. 5).
Thus, it appears that the factors which depress
plasma Ca in renal patients also alter the distribution
of Ca between compartments I and 2. Since the in-
creased exchangeable Ca and the increased soft tissue
Ca observed in uremia are reduced to normal following
subtotal parathyroidectomy [13], it is tempting to
speculate that the increased parathyroid hormone se-
cretion in patients with renal insufficiency has a role in
the observed altered Ca distribution. One possible
explanation for the marked increase in the exchange-
able Ca, compartment 2, concomitant with an essen-
tially normal total-body Ca, is the translocation of
skeletal Ca to soft tissue, mediated by the increased
parathyroid hormone secretion. Quite clearly, further
studies are required to substantiate this hypothesis,
namely, a quantitative measure of both soft tissue
and osseous Ca, as well as a measure of the level
of circulating parathyroid hormone.
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